Please ensure Javascript is enabled for purposes of website accessibility
After Bankruptcy Filing, Purdue Pharma May Not Be off Hook
gvw_ap_news
By Associated Press
Published 6 years ago on
September 16, 2019

Share

Purdue Pharma filed for bankruptcy in the first step in a complex, multibillion-dollar plan by the maker of OxyContin to settle thousands of lawsuits brought against it by state and local governments over the nation’s deadly opioid disaster.

About half the states and lawyers representing at least 1,000 local governments have agreed to the tentative settlement, which the company says could be worth $10 billion to $12 billion over time and would include at least $3 billion from the Sacklers.
The company and members of the Sackler family, which owns it, expressed sympathy but not responsibility.
“Like families across America, we have deep compassion for the victims of the opioid crisis,” family members said in a statement, calling the settlement plan a “historic step towards providing critical resources that address a tragic public health situation.”
But the bankruptcy filing, made late Sunday, may not get either the drugmaker or the Sacklers off the legal hook.
About half the states and lawyers representing at least 1,000 local governments have agreed to the tentative settlement, which the company says could be worth $10 billion to $12 billion over time and would include at least $3 billion from the Sacklers.
Under the settlement, the family would give up control of the company, and Purdue Pharma would be transformed into a sort of hybrid between a corporation and a charity. It would continue to sell opioids but its profits would be devoted to cleaning up the opioid mess and reimbursing state and local governments for the cost of the crisis that has killed more than 400,000 Americans in the past two decades.

The Company Is Facing Some 2,600 Lawsuits

But a number of the other states that are holding out have made it clear that they intend to object to the deal in bankruptcy court and seek to continue their lawsuits against members of the Sackler family.
“At every turn, we will fight their craven strategy to use bankruptcy to shield their wealth & to evade our claims to secure billions of dollars for addiction science & treatment,” Connecticut Attorney General William Tong tweeted Monday.
In all, the company is facing some 2,600 lawsuits, mostly from local governments.
It will be up to federal bankruptcy Judge Robert Drain in White Plains, New York, to decide whether to approve the settlement, and also whether those state lawsuits can continue. A court hearing on the bankruptcy plan is expected Tuesday.
For Purdue and the Sacklers, the effort revolves around getting more states to agree to the settlement, which could make approval more likely.
“We are hopeful that in time, those parties who are not yet supportive will ultimately shift their focus to the critical resources that the settlement provides to people and problems that need them,” the families of late company owners Mortimer and Raymond Sackler said in their statement.
The Sacklers were listed by Forbes magazine in 2016 as one of the 20 wealthiest families in the U.S. In a court filing last week, the New York attorney general’s office contended that the family had transferred $1 billion to itself through Swiss bank accounts and other means.

A Small Fraction of Prescription Opioids Shipped Over the Years

As some states agreed to the deal last week, others complained that it didn’t hold the family or company sufficiently accountable for their roles in the crisis.
In court filings, the family and the company have pushed back against accusations that the company played a central role in causing the crisis by overselling the benefits of its powerful prescription painkillers and downplaying the addiction risk.

“The resumption of litigation would rapidly diminish all the resources of the company and would be lose-lose-lose all the way around.” — Steve Miller, chairman of Purdue’s board of directors
The company’s drugs represent a small fraction of the prescription opioids shipped over the years — and most fatal overdoses have been linked to illegal opioids such as heroin and illicitly made fentanyl.
Steve Miller, chairman of Purdue’s board of directors, said on a conference call with reporters that an admission of wrongdoing is not part of the deal.
He warned that as legal battles drag on, the company’s costs grow, leaving less for the plaintiffs in lawsuits.
“The resumption of litigation would rapidly diminish all the resources of the company and would be lose-lose-lose all the way around,” he said.
One likely result of the company’s filing is that it will be removed from the first federal trial over the toll of opioids, scheduled to start Oct. 21 in Cleveland. Johnson & Johnson and its subsidiaries along with drug distributors and one pharmacy chain, Walgreens, remain as defendants.

DON'T MISS

Senate Rebukes Trump’s Tariffs as Some Republicans Vote to Halt Taxes on Canadian Imports

DON'T MISS

Supreme Court Sides With the FDA in Its Dispute Over Sweet-Flavored Vaping Products

DON'T MISS

Trump Announces Sweeping New Tariffs to Promote US Manufacturing, Risking Inflation and Trade Wars

DON'T MISS

Fresno Firefighters Save Dog From Canal and Now She’s Ready for Adoption

DON'T MISS

Big Brands Spend Just Enough on X to Avoid Musk’s ‘Naughty List’

DON'T MISS

Judge Dismisses Corruption Case Against New York City Mayor Eric Adams

DON'T MISS

State Center Trustees Render Split Decision on Future of PLAs

DON'T MISS

California’s Schools Chief Has a $200,000 Salary and a Side Gig

DON'T MISS

Why Project Labor Agreements Are Good for Our Schools and Students: Opinion

DON'T MISS

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

UP NEXT

Western US Sees Sharp Increase in Extreme Weather Impact

UP NEXT

7-Year-Old Girl Was Killed by a Falling Boulder at a Lake Tahoe Ski Resort

UP NEXT

Elon Musk Reclaims Top Spot on Forbes’ Billionaires List

UP NEXT

Lakers Hold Off Rockets With 6 3-Pointers Apiece From Dorian Finney-Smith, Gabe Vincent

UP NEXT

Athletics Bat Boy Stewart Thalblum Takes Down Drone in Left Field

UP NEXT

NFL Postpones Tush Push Decision but Passes Other Rule Changes, AP Source Says

UP NEXT

March Madness: It’s South Carolina vs. Texas and UCLA vs. UConn in Women’s Final Four

UP NEXT

Major Layoffs Begin at Health Agencies That Track Disease and Regulate Food

UP NEXT

U.S. Bank Executive Terry Dolan Dies in Plane Crash Near Minneapolis

UP NEXT

Top Vaccine Official Resigns From FDA, Criticizes RFK Jr. for Promoting Misinformation, Lies

Fresno Firefighters Save Dog From Canal and Now She’s Ready for Adoption

5 hours ago

Big Brands Spend Just Enough on X to Avoid Musk’s ‘Naughty List’

6 hours ago

Judge Dismisses Corruption Case Against New York City Mayor Eric Adams

6 hours ago

State Center Trustees Render Split Decision on Future of PLAs

6 hours ago

California’s Schools Chief Has a $200,000 Salary and a Side Gig

7 hours ago

Why Project Labor Agreements Are Good for Our Schools and Students: Opinion

7 hours ago

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

7 hours ago

Western US Sees Sharp Increase in Extreme Weather Impact

7 hours ago

Amazon Said to Make a Bid to Buy TikTok in the US

7 hours ago

Fresno Man Found Dead, Coroner’s Office Seeks Help Finding Family

7 hours ago

Senate Rebukes Trump’s Tariffs as Some Republicans Vote to Halt Taxes on Canadian Imports

WASHINGTON — The Senate passed a resolution Wednesday night that would thwart President Donald Trump’s ability to impose tariffs on Canada, ...

29 minutes ago

Senate Minority Leader Chuck Schumer, D-N.Y., center, is joined from left by Sen. Tim Kaine, D-Va., Sen. Peter Welch, D-Vt., and Sen. Angela Alsobrooks, D-Md., as they speak to reporters about President Donald Trump's tariffs on foreign countries, at the Capitol, in Washington, Wednesday, April 2, 2025. (AP Photo/J. Scott Applewhite)
29 minutes ago

Senate Rebukes Trump’s Tariffs as Some Republicans Vote to Halt Taxes on Canadian Imports

4 hours ago

Supreme Court Sides With the FDA in Its Dispute Over Sweet-Flavored Vaping Products

5 hours ago

Trump Announces Sweeping New Tariffs to Promote US Manufacturing, Risking Inflation and Trade Wars

A young Labrador mix rescued from a Fresno canal on Sunday, March 2, 2025, is thriving in a foster home after overcoming fear and trauma. (Instagram/Fresno Animal Center)
5 hours ago

Fresno Firefighters Save Dog From Canal and Now She’s Ready for Adoption

6 hours ago

Big Brands Spend Just Enough on X to Avoid Musk’s ‘Naughty List’

6 hours ago

Judge Dismisses Corruption Case Against New York City Mayor Eric Adams

6 hours ago

State Center Trustees Render Split Decision on Future of PLAs

7 hours ago

California’s Schools Chief Has a $200,000 Salary and a Side Gig

Help continue the work that gets you the news that matters most.

Search

Send this to a friend